The Role of the Epidermal Growth Factor Receptor in Breast Cancer

被引:0
|
作者
Samuel K. Chan
Mark E. Hill
William J. Gullick
机构
[1] Research School of Biosciences,Cancer Biology Laboratory
[2] University of Kent,undefined
[3] Kent Oncology Centre,undefined
关键词
Breast; ErbB; EGFR; Signal transduction; Hormone resistance; Gefitinib; Erlotinib;
D O I
暂无
中图分类号
学科分类号
摘要
Recent trials of drug therapy targeting the erbB receptor HER2 have met with success in breast cancer. The epidermal growth factor receptor or EGFR is a closely related receptor from this same family that is involved in cellular signal transduction and tumor cell growth and survival. Emerging evidence indicates that EGFR is implicated in the development of hormone-resistant breast cancer, and that its activity is intertwined with estrogen receptor. Here, the role of EGFR in breast cancer is reviewed, and data from selected clinical trials of signal transduction inhibition of this cellular target are summarized.
引用
收藏
页码:3 / 11
页数:8
相关论文
共 50 条
  • [41] Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer
    Lo, HW
    Xia, WY
    Wei, YK
    Ali-Seyed, M
    Huang, SF
    Hung, MC
    CANCER RESEARCH, 2005, 65 (01) : 338 - 348
  • [42] Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer
    Henson, Elizabeth S.
    Johnston, James B.
    Los, Marek
    Gibson, Spencer B.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (03): : 229 - 239
  • [43] Anti-epidermal growth factor receptor strategies for advanced breast cancer
    Campos, Susana M.
    CANCER INVESTIGATION, 2008, 26 (08) : 757 - 768
  • [44] Immunohistochemical expression and significance of epidermal growth factor receptor (EGFR) in breast cancer
    Meche, Adriana
    Cimpean, Anca Maria
    Raica, M.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2009, 50 (02): : 217 - 221
  • [45] Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells
    Yarden, RI
    Lauber, AH
    ElAshry, D
    Chrysogelos, SA
    ENDOCRINOLOGY, 1996, 137 (07) : 2739 - 2747
  • [46] Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
    Acharya, Sarbari
    Dilnawaz, Fahima
    Sahoo, Sanjeeb K.
    BIOMATERIALS, 2009, 30 (29) : 5737 - 5750
  • [47] Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer
    Tang, CK
    Gong, XQ
    Moscatello, DK
    Wong, AJ
    Lippman, ME
    CANCER RESEARCH, 2000, 60 (11) : 3081 - 3087
  • [48] Human Epidermal Growth Factor Receptor 2 "Low" in Breast Cancer in 2023
    Laffer, Shabnam
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (09) : 989 - 990
  • [49] Clinical value of epidermal growth factor receptor expression in primary breast cancer
    Rampaul, RS
    Pinder, SE
    Nicholson, RI
    Gullick, WJ
    Robertson, JF
    Ellis, IO
    ADVANCES IN ANATOMIC PATHOLOGY, 2005, 12 (05) : 271 - 273
  • [50] Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: A supporting role to the epidermal growth factor receptor
    Knowlden, JM
    Hutcheson, IR
    Barrow, D
    Gee, JMW
    Nicholson, RI
    ENDOCRINOLOGY, 2005, 146 (11) : 4609 - 4618